1. Home
  2. ONCO vs PPBT Comparison

ONCO vs PPBT Comparison

Compare ONCO & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • PPBT
  • Stock Information
  • Founded
  • ONCO 2018
  • PPBT 2010
  • Country
  • ONCO United States
  • PPBT Israel
  • Employees
  • ONCO N/A
  • PPBT N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ONCO Health Care
  • PPBT Health Care
  • Exchange
  • ONCO Nasdaq
  • PPBT Nasdaq
  • Market Cap
  • ONCO 9.4M
  • PPBT 8.7M
  • IPO Year
  • ONCO 2022
  • PPBT N/A
  • Fundamental
  • Price
  • ONCO $0.54
  • PPBT $3.10
  • Analyst Decision
  • ONCO
  • PPBT Strong Buy
  • Analyst Count
  • ONCO 0
  • PPBT 2
  • Target Price
  • ONCO N/A
  • PPBT $126.50
  • AVG Volume (30 Days)
  • ONCO 9.9M
  • PPBT 28.8K
  • Earning Date
  • ONCO 04-10-2025
  • PPBT 03-04-2025
  • Dividend Yield
  • ONCO N/A
  • PPBT N/A
  • EPS Growth
  • ONCO N/A
  • PPBT N/A
  • EPS
  • ONCO N/A
  • PPBT N/A
  • Revenue
  • ONCO $1,870,605.00
  • PPBT N/A
  • Revenue This Year
  • ONCO N/A
  • PPBT N/A
  • Revenue Next Year
  • ONCO N/A
  • PPBT N/A
  • P/E Ratio
  • ONCO N/A
  • PPBT N/A
  • Revenue Growth
  • ONCO N/A
  • PPBT N/A
  • 52 Week Low
  • ONCO $0.32
  • PPBT $2.00
  • 52 Week High
  • ONCO $21.40
  • PPBT $20.60
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 43.36
  • PPBT 41.53
  • Support Level
  • ONCO $0.53
  • PPBT $2.90
  • Resistance Level
  • ONCO $0.70
  • PPBT $3.20
  • Average True Range (ATR)
  • ONCO 0.06
  • PPBT 0.21
  • MACD
  • ONCO 0.00
  • PPBT 0.00
  • Stochastic Oscillator
  • ONCO 15.40
  • PPBT 42.19

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Share on Social Networks: